You have no items in your shopping cart.
Oncology Research Reagents
Cancer Biomarkers
Research in cancer is critical as it drives the discovery of new diagnostic tools, targeted therapies, and personalised treatments that improve outcomes for millions affected by cancer each year.
1. Molecular & Cellular Oncology
Understanding cancer at the molecular and cellular levels enables researchers to identify unique biomarkers, uncover therapeutic targets, and monitor disease progression with precision. By equipping scientists with tools tailored for oncology research, we aim to empower innovations that bring us closer to effective cancer diagnostics and treatments.
Did you know? We offer specialized tools for some of the most researched oncology biomarkers. These products facilitate a deeper understanding of cancer pathways, helping to drive discoveries in diagnostics and therapeutic targets.
2. Biomarkers by Organ System
Select an organ system below to explore our highly validated antibodies and assay kits targeting critical oncology biomarkers.
3. Product Categories
Our products are crafted for various applications, including detection, quantification, and functional assays. Each product is optimised to streamline cancer research processes and help you achieve high-quality, consistent data.
| Product Type | Description | Primary Applications | Example Targets |
|---|---|---|---|
| Antibodies | Specific antibodies for detecting cancer-related proteins, including monoclonal, polyclonal, and conjugated options. | Immunohistochemistry, Flow Cytometry, Western Blot | BRCA1 CD20 CEA |
| ELISA Kits | Sensitive, easy-to-use kits for quantifying cancer biomarkers in different sample types. | Biomarker quantification, diagnostics | AFP MMP-9 IL-6 |
| Proteins | Recombinant and native proteins involved in tumour biology and cellular signalling. | Binding studies, pathway analysis | EGF BRAF PDGF |
| Peptides | Functional peptides to study receptor interactions and pathway dynamics. | Functional assays, peptide competition | p53 MDM2 Akt |
| Small Molecules | Bioactive compounds for modulating cancer-relevant pathways. | Pathway modulation, drug screening | Rapamycin Dasatinib Erlotinib |
| RNA Probes | Probes targeting oncogene and tumour suppressor RNAs for hybridisation assays. | RNA detection, gene expression profiling | KRAS BCL2 TP53 |
| Cell Lysates | Ready-to-use cell lysates containing target proteins are ideal for controls or standards. | Western Blotting, ELISA, protein quantification | Jurkat Cell Lysate HeLa Membrane Lysate MCF 7 Membrane Lysate |
| Assay Kits | Kits for assessing cell viability, apoptosis, and DNA damage in oncology research. | Cell viability, apoptosis, oxidative stress | Annexin V Caspase-3 Microplate Assay Kit Reactive Oxygen Species Assay Kit |